Medical professional network Doximity (NYSE:DOCS) announced better-than-expected revenue in Q3 CY2025, with sales up 23.2% year on year to $168.5 million. The company expects next quarter’s revenue to be around $180.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.45 per share was 18.7% above analysts’ consensus estimates.
Doximity (DOCS) Q3 CY2025 Highlights:
Revenue: $168.5 million vs analyst estimates of $157.1 million (23.2% year-on-year growth, 7.2% beat)
Adjusted EPS: $0.45 vs analyst estimates of $0.38 (18.7% beat)
Adjusted Operating Income: $98.99 million vs analyst estimates of $85.38 million (58.7% margin, 15.9% beat)
The company lifted its revenue guidance for the full year to $643 million at the midpoint from $632 million, a 1.7% increase
EBITDA guidance for the full year is $354 million at the midpoint, above analyst estimates of $348.5 million
Operating Margin: 37.8%, down from 38.8% in the same quarter last year
Free Cash Flow Margin: 54.3%, up from 41.2% in the previous quarter
Market Capitalization: $11.99 billion
“Our platform continues to grow with new AI tools to save physicians’ time,” said Jeff Tangney, co-founder and CEO of Doximity.
Company Overview
With over 80% of U.S. physicians as members of its digital community, Doximity (NYSE:DOCS) operates a digital platform that enables physicians and other healthcare professionals to collaborate, stay current with medical news, manage their careers, and conduct virtual patient visits.
Doximity’s annualized revenue growth of 17.7% over the last two years is below its five-year trend
This quarter, Doximity reported robust year-on-year revenue growth of 23.2%, and its $168.5 million of revenue topped Wall Street estimates by 7.2%. Company management is currently guiding for a 7.1% year-on-year increase in sales next quarter.
https://finance.yahoo.com/news/doximity-nyse-docs-q3-beats-223300087.html
